Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis.

Trial Profile

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2011

At a glance

  • Drugs Thalidomide (Primary)
  • Indications Pelvic pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2011 Planned end date changed from 1 Nov 2010 to 1 Aug 2009 as reported by ClinicalTrials.gov.
    • 19 Dec 2011 Actual patient number (9) added as reported by ClinicalTrials.gov.
    • 05 Jan 2011 Planned end date changed from 1 Feb 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top